| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hims & Hers Health, Inc. (HIMS) has 15 insiders with recent SEC Form 4 filings, including 5 buys and 7 sells. HIMS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 460.9K | $15.08M | - | |
| COO | 432.1K | $14.13M | -14,027 | |
| Other | 176.4K | $5.77M | - | |
| CFO | 160.9K | $5.26M | - | |
| Other | 141.1K | $4.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2022 | Maltz Jules A.72 | Director, 10% Owner | Buy | 75,000 | $3.66 | $274,493.50 | +74.0% | +73.4% | +126.4% | |
| Jun 7, 2022 | Maltz Jules A.72 | Director, 10% Owner | Buy | 50,000 | $3.99 | $199,500.00 | New | +47.7% | +126.2% | |
| May 19, 2022 | Okupe Oluyemi55 | Chief Financial Officer | Buy | 7,500 | $3.52 | $26,399.25 | New | +89.6% | +175.2% | |
| Mar 17, 2022 | O'Keefe Lynne Chou | Director | Sell | 10,044 | $4.50 | $45,198.00 | -100% | -17.8% | +96.8% | |
| Mar 2, 2022 | O'Keefe Lynne Chou | Director | Sell | 40,178 | $5.04 | $202,497.12 | -100% | -22.5% | +98.7% | |
| Mar 1, 2022 | Becklund Irene | Pao | Sell | 14,585 | $5.26 | $76,644.18 | -57.0% | -20.0% | +128.3% | |
| Feb 28, 2022 | Carroll Patrick Harrison52 | Director | Sale+OE | 86,820 | $5.17 | $448,859.40 | -41.2% | -22.6% | +115.9% | |
| Feb 7, 2022 | Boughton Soleil | Chief Legal Officer | Sell | 24,516 | $4.41 | $108,115.56 | -6.9% | -20.4% | +81.3% | |
| Feb 4, 2022 | Boughton Soleil | Chief Legal Officer | Sell | 49,032 | $4.50 | $220,644.00 | -6.3% | -5.6% | +77.7% | |
| Jan 20, 2022 | Dudum Andrew48 | Chief Executive Officer | Buy | 1,500 | $5.17 | $7,755.00 | New | +1.9% | +50.6% |